See every side of every news story
Published loading...Updated

Productive and Durable Protein A Resins Bring Cost Efficiency to mAb Capture - Life Sciences British Columbia

Summary by lifesciencesbc.ca
Cytiva developed two new protein A resins: the MabSelect SuRe 70 and the MabSelect PrismA X to address the transformation of the mAb market.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

lifesciencesbc.ca broke the news in on Wednesday, April 2, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.